Beyond Air Inc. (XAIR)
NASDAQ: XAIR
· Real-Time Price · USD
2.45
-0.01 (-0.41%)
At close: Sep 29, 2025, 3:59 PM
2.45
0.00%
After-hours: Sep 29, 2025, 07:44 PM EDT
-0.41% (1D)
| Bid | 2.41 |
| Market Cap | 12.8M |
| Revenue (ttm) | 4.78M |
| Net Income (ttm) | -42.12M |
| EPS (ttm) | -10.01 |
| PE Ratio (ttm) | -0.24 |
| Forward PE | -0.63 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 2.53 |
| Volume | 228,373 |
| Avg. Volume (20D) | 3,012,538 |
| Open | 2.41 |
| Previous Close | 2.46 |
| Day's Range | 2.38 - 2.50 |
| 52-Week Range | 2.02 - 13.52 |
| Beta | 0.28 |
| Ex-Dividend Date | n/a |
About XAIR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol XAIR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for XAIR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsBeyond Air Inc. is scheduled to release its earnings on
Nov 10, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
-23.26%
Beyond Air shares are trading lower. The company r...
Unlock content with
Pro Subscription
3 weeks ago
+49.77%
NeuroNOS shares are trading higher after the company announced the FDA granted Orphan Drug Designation to BA-101 for the treatment of Glioblastoma.
